Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homocyst(e)ine and stroke.

Karen L Furie1, Peter J Kelly

  • 1Stroke Service, Massachusetts General Hospital, Harvard Medical School, Boston, 02114, USA.

Seminars in Neurology
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and External Validation of an Electronic Health Record-Derived Model for 30-Day Periprocedural Ischemic Stroke.

Journal of the American Heart Association·2026
Same author

Echocardiographic wall motion abnormalities in patients with stroke may warrant cardiac evaluation.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Impact of time to endovascular securement on outcomes in aneurysmal subarachnoid hemorrhage.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Secondary Prevention after Ischemic Stroke.

The New England journal of medicine·2026
Same author

Impact of Circle of Willis Anatomical Variations on Outcomes in Aneurysmal Subarachnoid Hemorrhage.

Neurocritical care·2025
Same author

Correction: Risk Factors for Opioid Utilization in Patients with Intracerebral Hemorrhage.

Neurocritical care·2025
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Elevated homocysteine levels significantly increase ischemic stroke risk. While genetic factors and vitamin deficiencies play a role, current research is exploring the benefits of vitamin supplementation for stroke prevention.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Nutritional Science

Background:

  • Elevated homocysteine (hyperhomocysteinemia) is a significant risk factor for ischemic stroke, increasing risk by two- to threefold.
  • Homocysteine levels are influenced by genetic factors regulating metabolic enzymes and by essential vitamin cofactors: folate, vitamin B6, and vitamin B12.
  • Genetic variations in key enzymes like methylenetetrahydrofolate reductase (MTHFR) and cystathionine beta-synthase (CBS) are linked to increased ischemic stroke risk.

Purpose of the Study:

  • To review the association between homocysteine levels and ischemic stroke risk.
  • To discuss the role of genetic and nutritional factors in hyperhomocysteinemia.
  • To evaluate the impact of interventions like folate fortification and vitamin supplementation on stroke risk.

Main Methods:

Related Experiment Videos

  • Literature review of studies investigating homocysteine metabolism, genetic associations, and vitamin supplementation trials related to stroke.
  • Analysis of the impact of public health initiatives such as folate fortification on population homocysteine levels.
  • Examination of clinical trial data, including the Vitamin Intervention in Stroke Prevention (VIST) study.

Main Results:

  • Homocysteine elevation is a confirmed risk factor for ischemic stroke through various mechanisms beyond large-artery atherosclerosis.
  • Genetic variations in homocysteine metabolism pathways contribute to stroke risk.
  • Folate fortification has demonstrably lowered homocysteine levels in the U.S. population.
  • The VIST study did not show a significant reduction in recurrent stroke or myocardial infarction with high-dose vitamin supplementation over 2 years.

Conclusions:

  • Hyperhomocysteinemia remains a critical factor in ischemic stroke etiology.
  • Screening for vitamin B12 deficiency is crucial, and awareness of potential vitamin B6 deficiency in specific populations is necessary.
  • While initial supplementation trials were inconclusive, ongoing research continues to explore the therapeutic potential of vitamin supplementation in stroke prevention.